Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2009-07-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Conjugated Linoleic Acid on Body Fat in Overweight Children
NCT00575991
Dietary Conjugated Linoleic Acid (CLA) Intake Among Students in Italy
NCT02335762
Conjugated Linoleic Acid and Atherosclerosis
NCT00706745
Supplementation of Alpha-linolenic Acid (ALA)-Rich Oil in Humans
NCT01317290
Influence of the Background Diet on Metabolism of Land-based n-3 PUFA
NCT03558776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CLA depletion-repletion
CLA depletion-repletion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CLA depletion-repletion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 20 to 40 years;
* BMI between 18.0 and 29.9 kg/m2.
Exclusion Criteria
* Smoker;
* Alcoholic;
* Under medication;
* History of chronic disease
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rio de Janeiro State University
OTHER
Alexandre Guedes Torres
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexandre Guedes Torres
Professor Alexandre Guedes Torres
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandre G Torres, DSc
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Rio de Janeiro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGT2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.